-
Real-World Differences in Breast Cancer Management by Detection Method: A Czech National Analysis
Sep 9, 2025, 16:22 PM -
EU HTA, Joint Clinical Assessment, and JCA Report: What Is the Possible Impact on Price Negotiation for Orphan Drugs in Germany?
Sep 9, 2025, 16:22 PM -
Satisfact-Home: Perception of Care Quality and Quality of Life in Patients With Solid Tumors Receiving Immune Checkpoint Inhibitors (ICIs) Therapy From Hospital To Home: A French Multicenter Prospective Observational Study
Sep 9, 2025, 16:22 PM -
Explaining Psychiatric Comorbidities in Patients With Skin Conditions: The Importance of Clinical Characteristics and Patient-Reported Disease Impact
Sep 9, 2025, 16:22 PM -
NICE Technology Appraisal Submissions for Non-Small Cell Lung Cancer: Analysis and Insights
Sep 9, 2025, 16:22 PM -
Effects of Antidepressant Drug Classes on Dementia Risk: A 23-Year Cohort Study Using Akrivia Health Secondary Mental Health Data
Sep 9, 2025, 16:22 PM -
Utilization of Informal WhatsApp for Pre- and Postnatal Referral Services in the Kwadaso Municipality of Ghana
Sep 9, 2025, 16:22 PM -
Estimated Healthcare Resource Utilization and Costs Associated With Semaglutide Life Expectancy Gains in a Real-World Population With CVD and Overweight or Obesity in the United Kingdom
Sep 9, 2025, 16:22 PM -
Evaluating Cost Benefits of Subcutaneous vs. Intravenous Trastuzumab/Pertuzumab in HER2-Positive Early Breast Cancer Patients: From Qatari Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Integrating Guidance Through a Whole Life-Cycle Approach: Wouldn’t It Be NICE?
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Malignant Non-Small Cell Lung Cancer (NSCLC) in the United States: A Surveillance Epidemiology and End Results (SEER) 2000-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Modeling the Healthcare Burden of Oral Corticosteroid Use in Mexico
Sep 9, 2025, 16:22 PM -
Urinary Dysfunction Management in Multiple Sclerosis: A Nationwide Real-Life Analysis From the French SNDS Database
Sep 9, 2025, 16:22 PM -
Unlocking Value: Assessing the Cost-Effectiveness of Pitolisant Wakix®in Portugal
Sep 9, 2025, 16:22 PM -
Eligibility and Strategic Implications of Germany’s 2025 Confidential Pricing Reform
Sep 9, 2025, 16:22 PM -
Relevance of Quality Indicators for Supporting Patients’ Choice of Hospitals: An Online Survey
Sep 9, 2025, 16:22 PM -
Effect of Positive Airway Pressure Therapy on Mortality in European Obstructive Sleep Apnea Patients: Post Hoc Analysis of a Global Meta-Analysis
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Pan-European Severity Assessment Methods and Their Uncertainty in Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Clinical Profile of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Treated With Complement Inhibitors: Results From a Real-World Study
Sep 9, 2025, 16:22 PM -
Navigating Joint Clinical Assessment in Europe: Strategic Roadmap and Recommendations for Health Technology Developers
Sep 9, 2025, 16:22 PM
